Last reviewed · How we verify
NCT06692777
Evaluation of the Hypolipidemic Effect of Bergavit by a Human Trial.
NA trial testing Bergavit in Hyperlipidemia in 120 participants. Completed in 31 October 2024.
30 September 2024
Quick facts
| Lead sponsor | Chung Shan Medical University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | prevention |
| Enrollment | 120 |
| Start date | 21 October 2023 |
| Primary completion | 30 September 2024 |
| Estimated completion | 31 October 2024 |
| Sites | 1 location across Taiwan |
Drugs / interventions tested
- Bergavit
- Placebo
Conditions studied
- Hyperlipidemia — all drugs for Hyperlipidemia →
Sponsor
Chung Shan Medical University
Who can join
Adults 40 to 70, any sex, with Hyperlipidemia. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Bergavit is a product contains bergamot. Bergamot is an endemic plant of the Calabrian region in southern Italy with a unique profile of flavonoids and flavonoid glycosides present in its juice and albedo, its flavonoids was able to reduce serum levels of lipids and ameliorate the thickening of the arteries through modulating enzymatic activities, anti-oxidation, anti-inflammatory mechanisms and inhibition of monocyte activation and proliferation.The primary outcome of the study the assessment of the the hypolipidemic effect of Bergavit. The secondary outcomes are the assessment of: a) the hypoglycemic effect of Bergavit, b) the activity of Bergavit on weight loss, and c) the hepatoprotective activity of Bergavit.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06692777
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Hyperlipidemia
Currently open trials in the same condition.
- NCT06966258 — Inspire HER: Inspiring the Heart and Emotions for Radical Health · NA · recruiting
- NCT07216482 — A Clinical Study of Enlicitide in Participants With High Cholesterol (MK-0616-037) · Phase 3 · recruiting
- NCT06615609 — "Smart Family Doctor" Assisted Comprehensive Management of Secondary Prevention Among Post Coronary Artery Bypass Graft · NA · recruiting
- NCT07400549 — Prospective Exploratory Study on the Comprehensive Application Effectiveness of Exercise Prescription Decision Support T · NA · recruiting
- NCT06603363 — Changes in Plaque Characteristics After Short-term Statin Therapy as Assessed With Coronary CT · NA · recruiting
Other Chung Shan Medical University trials
Trials by the same sponsor.
- NCT07443540 — The Effect of Acupuncture on Pulmonary Function Recovery Following Lung Resection · NA · not yet recruiting
- NCT07504029 — Human Clinical Trial Evaluating the Blood Glucose-Regulating Effects of Momordica Charantia Peptides · NA · recruiting
- NCT07252557 — Mouthwash Temperature and Oral Mucositis in Head and Neck Radiotherapy · NA · not yet recruiting
- NCT07282496 — Evaluation of VEDAN RT-90 Resistant Cassava Starch for Glycemic Control and Prebiotic Fiber Development in a Human Trial · NA · not yet recruiting
- NCT07504016 — Development of a Novel Cookie Formulation and Evaluation of Its Effects on Glycemic Control in Healthy Individuals · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06692777 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Chung Shan Medical University
- Last refreshed: 18 November 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06692777.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing